Wei-Fen Xie, M.D.
Shanghai Changzheng Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Wei-Fen Xie, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:48 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT06696248 · Carvedilol and Alverine in Portal HypertensionShanghai Changzheng Hospital · not yet recruiting · Hypertension, Portal · principal investigator
- Ph2/Ph3NCT06473493 · The Safety and Efficacy of Alverine in the Treatment of Cirrhotic Portal HypertensionShanghai Changzheng Hospital · unknown · Hypertension, Portal · principal investigator
- Ph2/Ph3NCT06470386 · The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver CirrhosisShanghai Changzheng Hospital · unknown · Hypertension, Portal · principal investigator
- Early Ph1NCT06418659 · A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC PatientsShanghai Changzheng Hospital · recruiting · Advanced Hepatocellular Carcinoma · principal investigator
- Early Ph1NCT06092112 · A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular CarcinomaShanghai Changzheng Hospital · completed · Advanced Hepatocellular Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.